The aim of this study is to determine whether it is feasible to deliver a 9-session compassionate-focused therapy for older people with bipolar disorder. Participants will be asked to complete baseline measures and at post-intervention follow-up (12 weeks and 24 weeks) to understand any potential clinical benefits of the therapy.
The present study will evaluate the feasibility of a compassionate-focused intervention targeting rumination that is specifically tailored for older people with bipolar disorder. In addition to evaluating its feasibility, the study will also investigate whether there are any clinical benefits associated with the intervention, namely, any potential reductions in negative rumination and feelings of guilt and shame. To date, there has been no research evaluating the feasibility of this type of intervention.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
6
A 9-session therapy intervention targeting negative thinking, feelings of guilt and shame, and cultivating compassion for self and others.
Greater Manchester Mental Health NHS Foundation Trust
Greater Manchester, United Kingdom
Number of therapy sessions attended
The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric.
Time frame: The timeframe for number of therapy sessions attended will span the length of intervention; from the first assessment session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks.
Number of participants who drop-out and at which stage of the intervention
The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric.
Time frame: The time frame covers first therapy session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks.
The Altman Self-Rating Mania Scale
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
The Bipolar Recovery Questionnaire
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
The Quality of Life in Bipolar Disorder Questionnaire
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
Other as Shamer Scale
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
Guilt and Shame Questionnaire
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
The Compassionate Engagement and Action Scale
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
Generalised Anxiety Disorder Questionnaire (GAD-7)
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up
Center for Epidemiologic Studies Depression Scale (CES-D)
Any preliminary potential clinical benefits will be determined using the following outcome measures.
Time frame: Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up